Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Poonam Jadhav

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
British Journal of Hospital Medicine (London, England : 2005)|September 6, 2022
Routine use of depth of anaesthesia monitoring in patients receiving volatile anaesthesia: is it worth it?Stephanie Glarbo, Poonam Jadhav, Yasser Mandour
Cellular and Molecular Neurobiology|January 23, 2022
Glial Cells Response in StrokePoonam Jadhav, Mayuri Karande, Abhishek Sarkar, et al.
JAMA Oncology|December 3, 2020
Efficacy of Capecitabine Plus Irinotecan vs Irinotecan Monotherapy as Second-line Treatment in Patients With Advanced Gallbladder Cancer: A Multicenter Phase 2 Randomized Clinical Trial (GB-SELECT)Anant Ramaswamy, Vikas Ostwal, Atul Sharma, et al.
Cancer|June 21, 2025
Efficacy of losartan plus modified FOLFIRINOX versus modified FOLFIRINOX in advanced pancreatic cancers: A randomized clinical trial (AFPAC Study)Anant Ramaswamy, Prabhat Bhargava, Vikram Gota, et al.
JCO Global Oncology|March 11, 2026
Carica Papaya Leaf Extract to Improve Chemotherapy-Induced Thrombocytopenia: A Phase III Triple-Blinded, Randomized, Placebo-Controlled, Multicentric TrialVikas Ostwal, Manali Parulekar, Deepali Naughane, et al.
JNCI Cancer Spectrum|July 27, 2024
Docetaxel-oxaliplatin-capecitabine/5-fluorouracil (DOX/F) followed by docetaxel versus oxaliplatin-capecitabine/5-fluorouracil (CAPOX/FOLFOX) in HER2-negative advanced gastric cancersAnant Ramaswamy, Prabhat Bhargava, Biswajit Dubashi, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
British Journal of Hospital Medicine (London, England : 2005)|September 6, 2022
Routine use of depth of anaesthesia monitoring in patients receiving volatile anaesthesia: is it worth it?Stephanie Glarbo, Poonam Jadhav, Yasser Mandour
Cellular and Molecular Neurobiology|January 23, 2022
Glial Cells Response in StrokePoonam Jadhav, Mayuri Karande, Abhishek Sarkar, et al.
JAMA Oncology|December 3, 2020
Efficacy of Capecitabine Plus Irinotecan vs Irinotecan Monotherapy as Second-line Treatment in Patients With Advanced Gallbladder Cancer: A Multicenter Phase 2 Randomized Clinical Trial (GB-SELECT)Anant Ramaswamy, Vikas Ostwal, Atul Sharma, et al.
Cancer|June 21, 2025
Efficacy of losartan plus modified FOLFIRINOX versus modified FOLFIRINOX in advanced pancreatic cancers: A randomized clinical trial (AFPAC Study)Anant Ramaswamy, Prabhat Bhargava, Vikram Gota, et al.
JCO Global Oncology|March 11, 2026
Carica Papaya Leaf Extract to Improve Chemotherapy-Induced Thrombocytopenia: A Phase III Triple-Blinded, Randomized, Placebo-Controlled, Multicentric TrialVikas Ostwal, Manali Parulekar, Deepali Naughane, et al.
JNCI Cancer Spectrum|July 27, 2024
Docetaxel-oxaliplatin-capecitabine/5-fluorouracil (DOX/F) followed by docetaxel versus oxaliplatin-capecitabine/5-fluorouracil (CAPOX/FOLFOX) in HER2-negative advanced gastric cancersAnant Ramaswamy, Prabhat Bhargava, Biswajit Dubashi, et al.
Pageof 1